HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mesenchymal stem cells induce granulocytic differentiation of acute promyelocytic leukemic cells via IL-6 and MEK/ERK pathways.

Abstract
All-trans retinoic acid (ATRA) induces clinical remission in most acute promyelocytic leukemia (APL) patients by inducing terminal differentiation of APL cells toward mature granulocytes. Here we report that human umbilical cord-derived mesenchymal stem cells (UC-MSCs) are capable of inducing granulocytic differentiation of the APL-derived NB4 cell line as well as primary APL cells and also cooperate with ATRA in an additive manner. Transwell coculture experiments revealed that UC-MSCs' differentiation-inducing effect was mediated through some soluble factors. Differentiation attenuation by IL-6Ra neutralization and induction by addition of exogenous IL-6 confirmed that IL-6 secreted by UC-MSCs was at least partially responsible for this differentiation induction process. Moreover, we found that UC-MSCs activated the MEK/ERK signaling pathway in promyelocytic cells and pharmacological inhibition of the MEK/ERK pathway reversed UC-MSC-induced differentiation, indicating that UC-MSCs exerted effect through activation of the MEK/ERK signaling pathway. These results demonstrate for the first time a stimulatory effect of MSCs on the differentiation of APL cells and bring a new insight into the interaction between MSCs and leukemic cells. Our data suggest that UC-MSCs/ATRA combination could be used as a novel therapeutic strategy for APL patients.
AuthorsFang Chen, Kang Zhou, Lei Zhang, Fengxia Ma, Dandan Chen, Junjie Cui, Xiaoming Feng, Shaoguang Yang, Ying Chi, Zhibo Han, Feng Xue, Lijuan Rong, Meili Ge, Li Wan, Shuxia Xu, Wenjing Du, Shihong Lu, Hongying Ren, Zhongchao Han
JournalStem cells and development (Stem Cells Dev) Vol. 22 Issue 13 Pg. 1955-67 (Jul 01 2013) ISSN: 1557-8534 [Electronic] United States
PMID23391335 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Interleukin-6
  • Tretinoin
Topics
  • Cell Differentiation (drug effects, genetics)
  • Cell Line, Tumor
  • Cell- and Tissue-Based Therapy
  • Granulocytes (cytology, metabolism)
  • Humans
  • Interleukin-6 (biosynthesis, genetics)
  • Leukemia, Promyelocytic, Acute (pathology, therapy)
  • MAP Kinase Signaling System (genetics)
  • Mesenchymal Stem Cells (cytology, drug effects)
  • Tretinoin (pharmacology)
  • Umbilical Cord (cytology, drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: